Multiplex Assay Market Report: Revenue Analysis, Statistics and Outlook, Forecast to 2027
In July 2021, DiaSorin S.p.A. acquired the leading company of multiplex assays, Luminex Corporation, for a price of USD 37.00 per share, that corresponds to a total equity value of approximately USD 1.8 billion.
View full press release